1. Pet care ecosystem scale-up - Pet care is already at ₹40-43 cr revenue and management targets ₹100 cr within 3-3.5 years, with 40-50% YoY growth for the next 3-4 years. The Wagr marketplace, One Pet Stop grooming, and India's first pet diagnostic centre give it a platform no Indian competitor matches.
2. Wagr marketplace launch - Wagr relaunches as a neutral pet products marketplace in Q4 FY 2025-26, with all platform sales booked under Fredun's revenue regardless of brand. With 140,000+ registered pet parents and 70+ brand relationships already acquired at zero cash cost, this adds a high-margin digital revenue stream on top of the physical product business.
3. Generics registration pipeline - Fredun Gx holds 697 product registrations across 52 countries with over 1,200 more under registration, and management expects 25-35% YoY growth for the next 5 years. The TNMSC tender worth ₹15-18 cr adds institutional visibility on top of the export base.
4. Mobility distribution expansion - Mobility is adding 30-40 retail outlets weekly and entering Goa, Chhattisgarh, and Karnataka next, targeting ₹100 cr run rate within 2-2.5 years from \~₹30 cr today. The physiotherapist-focused Mobilitics line is fully pre-booked at launch, adding a new channel with higher margins.
5. Hormonal and anti-aging lines - Management is launching a hormonal line (testosterone, pregnancy, estrogen) where it will be 1st or 2nd in India for some products, plus an anti-aging line with exclusive import rights for NAD+ API. These are high-margin, doctor-channel products in fragmented markets, and the first-to-market position supports premium pricing.
6. Functional foods plant - The Palghar functional foods plant for pets begins operations in Q3 FY26, producing biscuits and therapeutic foods for chronic conditions, with 42 variants launching. This converts the pet care pipeline from imported/third-party products to in-house manufacturing, improving gross margins and enabling white-label revenue.
7. Packing capacity expansion - The company is adding 12-13 packing lines by end-September and has tripled tube filling capacity with a second Italian machine, with an order book of 2 crore tubes in hand. This removes the main bottleneck for the topical and ointment business, which is already running at high utilisation.
8. Working capital efficiency - Inventory days are targeted to fall from \~135-140 to \~120 within four quarters, down \~50% over two years, with operating cash flows now positive. Each day of inventory released converts directly to cash, funding the ₹153 cr preferential issue's working capital needs without additional debt.